Cite

HARVARD Citation

    Kolb, E. et al. (n.d.). Initial testing (stage 1) of eribulin, a novel tubulin binding agent, by the pediatric preclinical testing program. Pediatric blood & cancer. 60 (8), pp. 1325-1332. [Online]. 
  
Back to record